Pricing Log in Create free account

Jasper Therapeutics, Inc. (JSPR) vs NewcelX Ltd. (NCEL)

Jasper Therapeutics, Inc. and NewcelX Ltd. are both Biotechnology companies. Jasper Therapeutics, Inc. and NewcelX Ltd. are of similar size ($15.6M and $15.6M). Across the 9 metrics below, Jasper Therapeutics, Inc. leads on 6 and NewcelX Ltd. on 3.

Valuation

Metric JSPR NCEL Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 339.77 5.02 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (9.50%) (56.25%) (32.88%)
Free cash flow yield (12.55%) (16.18%) (23.13%)

Profitability

Metric JSPR NCEL Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (255.05%) 0.00% (51.96%)
Return on assets (109.05%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric JSPR NCEL Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 19.22% 11.18% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric JSPR NCEL Biotechnology median
Debt to equity 0.00 0.06 0.00
Current ratio 1.48 0.40 4.97
Net debt to EBITDA 0.35 0.74 1.01

Dividend

Metric JSPR NCEL Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric JSPR NCEL Biotechnology median
Market cap 15.62m 15.56m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack